Utges J, Barton G
J Cheminform. 2024; 16(1):126.
PMID: 39529176
PMC: 11552181.
DOI: 10.1186/s13321-024-00923-z.
Preynat-Seauve O, Nguyen E, Westermaier Y, Heritier M, Tardy S, Cambet Y
Front Pharmacol. 2021; 12:664608.
PMID: 34421588
PMC: 8371461.
DOI: 10.3389/fphar.2021.664608.
Ma Z, Huang S, Cheng F, Zou X
J Phys Chem B. 2021; 125(9):2288-2298.
PMID: 33651624
PMC: 8991440.
DOI: 10.1021/acs.jpcb.1c00016.
Homeyer N, van Deursen R, Ochoa-Montano B, Heikamp K, Ray P, Zuccotto F
J Mol Graph Model. 2019; 95:107485.
PMID: 31836397
PMC: 6983931.
DOI: 10.1016/j.jmgm.2019.107485.
Playe B, Azencott C, Stoven V
PLoS One. 2018; 13(10):e0204999.
PMID: 30286165
PMC: 6171913.
DOI: 10.1371/journal.pone.0204999.
Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds.
Huang H, Zhang G, Zhou Y, Lin C, Chen S, Lin Y
Front Chem. 2018; 6:138.
PMID: 29868550
PMC: 5954125.
DOI: 10.3389/fchem.2018.00138.
Using reverse docking to identify potential targets for ginsenosides.
Park K, Cho A
J Ginseng Res. 2017; 41(4):534-539.
PMID: 29021701
PMC: 5628352.
DOI: 10.1016/j.jgr.2016.10.005.
Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes.
Zuraidah Mohamad Zobir S, Mohd Fauzi F, Liggi S, Drakakis G, Fu X, Fan T
Evid Based Complement Alternat Med. 2016; 2016:2106465.
PMID: 26989424
PMC: 4775820.
DOI: 10.1155/2016/2106465.
Historeceptomic Fingerprints for Drug-Like Compounds.
Shmelkov E, Grigoryan A, Swetnam J, Xin J, Tivon D, Shmelkov S
Front Physiol. 2016; 6:371.
PMID: 26733872
PMC: 4683199.
DOI: 10.3389/fphys.2015.00371.
RepurposeVS: A Drug Repurposing-Focused Computational Method for Accurate Drug-Target Signature Predictions.
Issa N, Peters O, Byers S, Dakshanamurthy S
Comb Chem High Throughput Screen. 2015; 18(8):784-94.
PMID: 26234515
PMC: 5848469.
DOI: 10.2174/1386207318666150803130138.
Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design.
Grinter S, Zou X
Molecules. 2014; 19(7):10150-76.
PMID: 25019558
PMC: 6270832.
DOI: 10.3390/molecules190710150.
New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery.
Tang Y, Zhu W, Chen K, Jiang H
Drug Discov Today Technol. 2014; 3(3):307-13.
PMID: 24980533
PMC: 7185835.
DOI: 10.1016/j.ddtec.2006.09.004.
Computational methods for drug design and discovery: focus on China.
Zheng M, Liu X, Xu Y, Li H, Luo C, Jiang H
Trends Pharmacol Sci. 2013; 34(10):549-59.
PMID: 24035675
PMC: 7126378.
DOI: 10.1016/j.tips.2013.08.004.
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.
Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W
J Comput Aided Mol Des. 2013; 27(3):221-34.
PMID: 23579614
DOI: 10.1007/s10822-013-9644-8.
Large-scale reverse docking profiles and their applications.
Lee M, Kim D
BMC Bioinformatics. 2013; 13 Suppl 17:S6.
PMID: 23282219
PMC: 3521474.
DOI: 10.1186/1471-2105-13-S17-S6.
Computational drug discovery.
Ou-Yang S, Lu J, Kong X, Liang Z, Luo C, Jiang H
Acta Pharmacol Sin. 2012; 33(9):1131-40.
PMID: 22922346
PMC: 4003107.
DOI: 10.1038/aps.2012.109.
Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements.
Defranchi E, De Franchi E, Schalon C, Messa M, Onofri F, Benfenati F
PLoS One. 2010; 5(8):e12214.
PMID: 20808948
PMC: 2922380.
DOI: 10.1371/journal.pone.0012214.
Mechanisms of drug combinations: interaction and network perspectives.
Jia J, Zhu F, Ma X, Cao Z, Cao Z, Li Y
Nat Rev Drug Discov. 2009; 8(2):111-28.
PMID: 19180105
DOI: 10.1038/nrd2683.
Improving accuracy and efficiency of blind protein-ligand docking by focusing on predicted binding sites.
Ghersi D, Sanchez R
Proteins. 2008; 74(2):417-24.
PMID: 18636505
PMC: 2610246.
DOI: 10.1002/prot.22154.
Being a binding site: characterizing residue composition of binding sites on proteins.
Ivan G, Szabadka Z, Grolmusz V
Bioinformation. 2008; 2(5):216-21.
PMID: 18305831
PMC: 2241929.
DOI: 10.6026/97320630002216.